The global Stable Isotope Labeled Biomolecules market was valued at 112.67 Million USD in 2020 and will grow with a CAGR of 2.82% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
This report studies the Stable Isotope Labeled Biomolecules market, Stable Isotope Labeled Biomolecules refer to the biomolecule which is labeled by replacing specific atoms by their isotope, and then the reactant is then allowed to undergo the reaction. An important tool for high-resolution structure determination for NMR spectroscopy is the use of stable isotopically labeled biomolecules. By either selectively or uniformly incorporating stable isotopes into proteins, the user is able to significantly reduce the complexity of their spectra. D Labeled Biomolecules, 15N, and deuterium are the most common isotopes incorporated into proteins. Microbial expression systems, cell-free extracts, peptide synthesis and custom synthesis provide a variety of options for accomplishing the incorporation of the labels. Microbial expression systems are cell-based protein expression systems in which the microbes are grown in either a defined or complex media with D Labeled Biomolecules labeled glucoses and 15N Labeled Biomoleculeslabeled ammonium salts as the sole sources of carbon and nitrogen respectively. Ease of use, adaptability and high protein yields have made these expression systems the most popular technique for stable isotope incorporation. Cell-free extracts and custom synthesis also present their own individual advantages with the use of uniformly or selectively labeled amino acids. Cell-free extracts allow the user to more readily implement high-throughput in vitro protein expression as many proteins are difficult to express in vivo due to complications such as toxicity. Custom synthesis allows for unique, site-specific incorporation of isotopes into peptides allowing the user to study distinct structural regions. North America is the largest consumer by regions. North America accounted about 52.63% consumption market share in 2016. Europe is the second largest with 33.92% market share. China is the following consumption region with 5.53% consumption market share.
By Market Verdors:
Cambridge Isotope Laboratories
Sigma-Aldrich
Thermo Fisher Scientific
LGC Standards
Toronto Research Chemicals
IsoLife
WITEGA Laboratorien
Omicron Biochemicals
Icon Isotopes
Medical Isotopes
By Types:
D Labeled Biomolecules
15N Labeled Biomolecules
13C Labeled Biomolecules
By Applications:
Scientific Research
Medical
Industrial
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Stable Isotope Labeled Biomolecules Market Size Analysis from 2022 to 2027
1.5.1 Global Stable Isotope Labeled Biomolecules Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Stable Isotope Labeled Biomolecules Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Stable Isotope Labeled Biomolecules Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Stable Isotope Labeled Biomolecules Industry Impact
Chapter 2 Global Stable Isotope Labeled Biomolecules Competition by Types, Applications, and Top Regions and Countries
2.1 Global Stable Isotope Labeled Biomolecules (Volume and Value) by Type
2.1.1 Global Stable Isotope Labeled Biomolecules Consumption and Market Share by Type (2016-2021)
2.1.2 Global Stable Isotope Labeled Biomolecules Revenue and Market Share by Type (2016-2021)
2.2 Global Stable Isotope Labeled Biomolecules (Volume and Value) by Application
2.2.1 Global Stable Isotope Labeled Biomolecules Consumption and Market Share by Application (2016-2021)
2.2.2 Global Stable Isotope Labeled Biomolecules Revenue and Market Share by Application (2016-2021)
2.3 Global Stable Isotope Labeled Biomolecules (Volume and Value) by Regions
2.3.1 Global Stable Isotope Labeled Biomolecules Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Stable Isotope Labeled Biomolecules Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Stable Isotope Labeled Biomolecules Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Stable Isotope Labeled Biomolecules Consumption by Regions (2016-2021)
4.2 North America Stable Isotope Labeled Biomolecules Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Stable Isotope Labeled Biomolecules Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Stable Isotope Labeled Biomolecules Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Stable Isotope Labeled Biomolecules Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Stable Isotope Labeled Biomolecules Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Stable Isotope Labeled Biomolecules Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Stable Isotope Labeled Biomolecules Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Stable Isotope Labeled Biomolecules Sales, Consumption, Export, Import (2016-2021)
4.10 South America Stable Isotope Labeled Biomolecules Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Stable Isotope Labeled Biomolecules Market Analysis
5.1 North America Stable Isotope Labeled Biomolecules Consumption and Value Analysis
5.1.1 North America Stable Isotope Labeled Biomolecules Market Under COVID-19
5.2 North America Stable Isotope Labeled Biomolecules Consumption Volume by Types
5.3 North America Stable Isotope Labeled Biomolecules Consumption Structure by Application
5.4 North America Stable Isotope Labeled Biomolecules Consumption by Top Countries
5.4.1 United States Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
5.4.2 Canada Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
5.4.3 Mexico Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
Chapter 6 East Asia Stable Isotope Labeled Biomolecules Market Analysis
6.1 East Asia Stable Isotope Labeled Biomolecules Consumption and Value Analysis
6.1.1 East Asia Stable Isotope Labeled Biomolecules Market Under COVID-19
6.2 East Asia Stable Isotope Labeled Biomolecules Consumption Volume by Types
6.3 East Asia Stable Isotope Labeled Biomolecules Consumption Structure by Application
6.4 East Asia Stable Isotope Labeled Biomolecules Consumption by Top Countries
6.4.1 China Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
6.4.2 Japan Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
6.4.3 South Korea Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
Chapter 7 Europe Stable Isotope Labeled Biomolecules Market Analysis
7.1 Europe Stable Isotope Labeled Biomolecules Consumption and Value Analysis
7.1.1 Europe Stable Isotope Labeled Biomolecules Market Under COVID-19
7.2 Europe Stable Isotope Labeled Biomolecules Consumption Volume by Types
7.3 Europe Stable Isotope Labeled Biomolecules Consumption Structure by Application
7.4 Europe Stable Isotope Labeled Biomolecules Consumption by Top Countries
7.4.1 Germany Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
7.4.2 UK Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
7.4.3 France Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
7.4.4 Italy Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
7.4.5 Russia Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
7.4.6 Spain Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
7.4.7 Netherlands Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
7.4.8 Switzerland Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
7.4.9 Poland Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
Chapter 8 South Asia Stable Isotope Labeled Biomolecules Market Analysis
8.1 South Asia Stable Isotope Labeled Biomolecules Consumption and Value Analysis
8.1.1 South Asia Stable Isotope Labeled Biomolecules Market Under COVID-19
8.2 South Asia Stable Isotope Labeled Biomolecules Consumption Volume by Types
8.3 South Asia Stable Isotope Labeled Biomolecules Consumption Structure by Application
8.4 South Asia Stable Isotope Labeled Biomolecules Consumption by Top Countries
8.4.1 India Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
8.4.2 Pakistan Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Stable Isotope Labeled Biomolecules Market Analysis
9.1 Southeast Asia Stable Isotope Labeled Biomolecules Consumption and Value Analysis
9.1.1 Southeast Asia Stable Isotope Labeled Biomolecules Market Under COVID-19
9.2 Southeast Asia Stable Isotope Labeled Biomolecules Consumption Volume by Types
9.3 Southeast Asia Stable Isotope Labeled Biomolecules Consumption Structure by Application
9.4 Southeast Asia Stable Isotope Labeled Biomolecules Consumption by Top Countries
9.4.1 Indonesia Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
9.4.2 Thailand Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
9.4.3 Singapore Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
9.4.4 Malaysia Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
9.4.5 Philippines Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
9.4.6 Vietnam Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
9.4.7 Myanmar Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
Chapter 10 Middle East Stable Isotope Labeled Biomolecules Market Analysis
10.1 Middle East Stable Isotope Labeled Biomolecules Consumption and Value Analysis
10.1.1 Middle East Stable Isotope Labeled Biomolecules Market Under COVID-19
10.2 Middle East Stable Isotope Labeled Biomolecules Consumption Volume by Types
10.3 Middle East Stable Isotope Labeled Biomolecules Consumption Structure by Application
10.4 Middle East Stable Isotope Labeled Biomolecules Consumption by Top Countries
10.4.1 Turkey Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
10.4.3 Iran Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
10.4.5 Israel Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
10.4.6 Iraq Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
10.4.7 Qatar Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
10.4.8 Kuwait Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
10.4.9 Oman Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
Chapter 11 Africa Stable Isotope Labeled Biomolecules Market Analysis
11.1 Africa Stable Isotope Labeled Biomolecules Consumption and Value Analysis
11.1.1 Africa Stable Isotope Labeled Biomolecules Market Under COVID-19
11.2 Africa Stable Isotope Labeled Biomolecules Consumption Volume by Types
11.3 Africa Stable Isotope Labeled Biomolecules Consumption Structure by Application
11.4 Africa Stable Isotope Labeled Biomolecules Consumption by Top Countries
11.4.1 Nigeria Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
11.4.2 South Africa Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
11.4.3 Egypt Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
11.4.4 Algeria Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
11.4.5 Morocco Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
Chapter 12 Oceania Stable Isotope Labeled Biomolecules Market Analysis
12.1 Oceania Stable Isotope Labeled Biomolecules Consumption and Value Analysis
12.2 Oceania Stable Isotope Labeled Biomolecules Consumption Volume by Types
12.3 Oceania Stable Isotope Labeled Biomolecules Consumption Structure by Application
12.4 Oceania Stable Isotope Labeled Biomolecules Consumption by Top Countries
12.4.1 Australia Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
12.4.2 New Zealand Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
Chapter 13 South America Stable Isotope Labeled Biomolecules Market Analysis
13.1 South America Stable Isotope Labeled Biomolecules Consumption and Value Analysis
13.1.1 South America Stable Isotope Labeled Biomolecules Market Under COVID-19
13.2 South America Stable Isotope Labeled Biomolecules Consumption Volume by Types
13.3 South America Stable Isotope Labeled Biomolecules Consumption Structure by Application
13.4 South America Stable Isotope Labeled Biomolecules Consumption Volume by Major Countries
13.4.1 Brazil Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
13.4.2 Argentina Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
13.4.3 Columbia Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
13.4.4 Chile Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
13.4.5 Venezuela Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
13.4.6 Peru Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
13.4.8 Ecuador Stable Isotope Labeled Biomolecules Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Stable Isotope Labeled Biomolecules Business
14.1 Cambridge Isotope Laboratories
14.1.1 Cambridge Isotope Laboratories Company Profile
14.1.2 Cambridge Isotope Laboratories Stable Isotope Labeled Biomolecules Product Specification
14.1.3 Cambridge Isotope Laboratories Stable Isotope Labeled Biomolecules Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Sigma-Aldrich
14.2.1 Sigma-Aldrich Company Profile
14.2.2 Sigma-Aldrich Stable Isotope Labeled Biomolecules Product Specification
14.2.3 Sigma-Aldrich Stable Isotope Labeled Biomolecules Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Thermo Fisher Scientific
14.3.1 Thermo Fisher Scientific Company Profile
14.3.2 Thermo Fisher Scientific Stable Isotope Labeled Biomolecules Product Specification
14.3.3 Thermo Fisher Scientific Stable Isotope Labeled Biomolecules Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 LGC Standards
14.4.1 LGC Standards Company Profile
14.4.2 LGC Standards Stable Isotope Labeled Biomolecules Product Specification
14.4.3 LGC Standards Stable Isotope Labeled Biomolecules Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Toronto Research Chemicals
14.5.1 Toronto Research Chemicals Company Profile
14.5.2 Toronto Research Chemicals Stable Isotope Labeled Biomolecules Product Specification
14.5.3 Toronto Research Chemicals Stable Isotope Labeled Biomolecules Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 IsoLife
14.6.1 IsoLife Company Profile
14.6.2 IsoLife Stable Isotope Labeled Biomolecules Product Specification
14.6.3 IsoLife Stable Isotope Labeled Biomolecules Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 WITEGA Laboratorien
14.7.1 WITEGA Laboratorien Company Profile
14.7.2 WITEGA Laboratorien Stable Isotope Labeled Biomolecules Product Specification
14.7.3 WITEGA Laboratorien Stable Isotope Labeled Biomolecules Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Omicron Biochemicals
14.8.1 Omicron Biochemicals Company Profile
14.8.2 Omicron Biochemicals Stable Isotope Labeled Biomolecules Product Specification
14.8.3 Omicron Biochemicals Stable Isotope Labeled Biomolecules Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Icon Isotopes
14.9.1 Icon Isotopes Company Profile
14.9.2 Icon Isotopes Stable Isotope Labeled Biomolecules Product Specification
14.9.3 Icon Isotopes Stable Isotope Labeled Biomolecules Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Medical Isotopes
14.10.1 Medical Isotopes Company Profile
14.10.2 Medical Isotopes Stable Isotope Labeled Biomolecules Product Specification
14.10.3 Medical Isotopes Stable Isotope Labeled Biomolecules Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Stable Isotope Labeled Biomolecules Market Forecast (2022-2027)
15.1 Global Stable Isotope Labeled Biomolecules Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Stable Isotope Labeled Biomolecules Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Stable Isotope Labeled Biomolecules Value and Growth Rate Forecast (2022-2027)
15.2 Global Stable Isotope Labeled Biomolecules Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Stable Isotope Labeled Biomolecules Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Stable Isotope Labeled Biomolecules Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Stable Isotope Labeled Biomolecules Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Stable Isotope Labeled Biomolecules Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Stable Isotope Labeled Biomolecules Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Stable Isotope Labeled Biomolecules Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Stable Isotope Labeled Biomolecules Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Stable Isotope Labeled Biomolecules Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Stable Isotope Labeled Biomolecules Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Stable Isotope Labeled Biomolecules Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Stable Isotope Labeled Biomolecules Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Stable Isotope Labeled Biomolecules Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Stable Isotope Labeled Biomolecules Consumption Forecast by Type (2022-2027)
15.3.2 Global Stable Isotope Labeled Biomolecules Revenue Forecast by Type (2022-2027)
15.3.3 Global Stable Isotope Labeled Biomolecules Price Forecast by Type (2022-2027)
15.4 Global Stable Isotope Labeled Biomolecules Consumption Volume Forecast by Application (2022-2027)
15.5 Stable Isotope Labeled Biomolecules Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Request Sample 
Request Discount 
Inquire Before Buy
